Tags

Type your tag names separated by a space and hit enter

µ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects.
Acta Pharmacol Sin. 2019 Jul; 40(7):859-866.AP

Abstract

Human genetic and pharmacological studies have demonstrated that voltage-gated sodium channels (VGSCs) are promising therapeutic targets for the treatment of pain. Spider venom contains many toxins that modulate the activity of VGSCs. To date, only 0.01% of such spider toxins has been explored, and thus there is a great potential for discovery of novel VGSC modulators as useful pharmacological tools or potential therapeutics. In the current study, we identified a novel peptide, µ-TRTX-Ca1a (Ca1a), in the venom of the tarantula Cyriopagopus albostriatus. This peptide consisted of 38 residues, including 6 cysteines, i.e. IFECSISCEIEKEGNGKKCKPKKCKGGWKCKFNICVKV. In HEK293T or ND7/23 cells expressing mammalian VGSCs, this peptide exhibited the strongest inhibitory activity on Nav1.7 (IC50 378 nM), followed by Nav1.6 (IC50 547 nM), Nav1.2 (IC50 728 nM), Nav1.3 (IC50 2.2 µM) and Nav1.4 (IC50 3.2 µM), and produced negligible inhibitory effect on Nav1.5, Nav1.8, and Nav1.9, even at high concentrations of up to 10 µM. Furthermore, this peptide did not significantly affect the activation and inactivation of Nav1.7. Using site-directed mutagenesis of Nav1.7 and Nav1.4, we revealed that its binding site was localized to the DIIS3-S4 linker region involving the D816 and E818 residues. In three different mouse models of pain, pretreatment with Cala (100, 200, 500 µg/kg) dose-dependently suppressed the nociceptive responses induced by formalin, acetic acid or heat. These results suggest that Ca1a is a novel neurotoxin against VGSCs and has a potential to be developed as a novel analgesic.

Authors+Show Affiliations

The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha 410081, China.The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha 410081, China.The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha 410081, China.The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha 410081, China.The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha 410081, China.The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha 410081, China.The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha 410081, China.The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha 410081, China. rongmq@hunnu.edu.cn.The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha 410081, China. liuzh@hunnu.edu.cn.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

30382183

Citation

Zhang, Yun-Xiao, et al. "Μ-TRTX-Ca1a: a Novel Neurotoxin From Cyriopagopus Albostriatus With Analgesic Effects." Acta Pharmacologica Sinica, vol. 40, no. 7, 2019, pp. 859-866.
Zhang YX, Peng DZ, Zhang QF, et al. Μ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects. Acta Pharmacol Sin. 2019;40(7):859-866.
Zhang, Y. X., Peng, D. Z., Zhang, Q. F., Huang, B., Yang, Q. C., Tang, D. F., Chen, M. Z., Rong, M. Q., & Liu, Z. H. (2019). Μ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects. Acta Pharmacologica Sinica, 40(7), 859-866. https://doi.org/10.1038/s41401-018-0181-9
Zhang YX, et al. Μ-TRTX-Ca1a: a Novel Neurotoxin From Cyriopagopus Albostriatus With Analgesic Effects. Acta Pharmacol Sin. 2019;40(7):859-866. PubMed PMID: 30382183.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - µ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects. AU - Zhang,Yun-Xiao, AU - Peng,De-Zheng, AU - Zhang,Qing-Feng, AU - Huang,Biao, AU - Yang,Qiu-Chu, AU - Tang,Dong-Fang, AU - Chen,Min-Zhi, AU - Rong,Ming-Qiang, AU - Liu,Zhong-Hua, Y1 - 2018/10/31/ PY - 2018/06/06/received PY - 2018/09/30/accepted PY - 2018/11/2/pubmed PY - 2020/1/14/medline PY - 2018/11/2/entrez KW - analgesic activity KW - electrophysiology KW - hNav1.7 KW - peptide KW - tarantula spider KW - µ-TRTX-Ca1a SP - 859 EP - 866 JF - Acta pharmacologica Sinica JO - Acta Pharmacol Sin VL - 40 IS - 7 N2 - Human genetic and pharmacological studies have demonstrated that voltage-gated sodium channels (VGSCs) are promising therapeutic targets for the treatment of pain. Spider venom contains many toxins that modulate the activity of VGSCs. To date, only 0.01% of such spider toxins has been explored, and thus there is a great potential for discovery of novel VGSC modulators as useful pharmacological tools or potential therapeutics. In the current study, we identified a novel peptide, µ-TRTX-Ca1a (Ca1a), in the venom of the tarantula Cyriopagopus albostriatus. This peptide consisted of 38 residues, including 6 cysteines, i.e. IFECSISCEIEKEGNGKKCKPKKCKGGWKCKFNICVKV. In HEK293T or ND7/23 cells expressing mammalian VGSCs, this peptide exhibited the strongest inhibitory activity on Nav1.7 (IC50 378 nM), followed by Nav1.6 (IC50 547 nM), Nav1.2 (IC50 728 nM), Nav1.3 (IC50 2.2 µM) and Nav1.4 (IC50 3.2 µM), and produced negligible inhibitory effect on Nav1.5, Nav1.8, and Nav1.9, even at high concentrations of up to 10 µM. Furthermore, this peptide did not significantly affect the activation and inactivation of Nav1.7. Using site-directed mutagenesis of Nav1.7 and Nav1.4, we revealed that its binding site was localized to the DIIS3-S4 linker region involving the D816 and E818 residues. In three different mouse models of pain, pretreatment with Cala (100, 200, 500 µg/kg) dose-dependently suppressed the nociceptive responses induced by formalin, acetic acid or heat. These results suggest that Ca1a is a novel neurotoxin against VGSCs and has a potential to be developed as a novel analgesic. SN - 1745-7254 UR - https://www.unboundmedicine.com/medline/citation/30382183/µ_TRTX_Ca1a:_a_novel_neurotoxin_from_Cyriopagopus_albostriatus_with_analgesic_effects_ L2 - https://doi.org/10.1038/s41401-018-0181-9 DB - PRIME DP - Unbound Medicine ER -